Mild renal dysfunction as a non-traditional cardiovascular risk factor?-Association of cystatin C-based glomerular filtration rate with flow-mediated vasodilation

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 660-666

  Reffelmann, Thorsten ^a   Krebs, Alexander ^a   Ittermann, Till ^a,b   Empen, Klaus ^a   Hummel, Astrid ^a   Dörr, Marcus ^a   Völzke, Henry ^b   Felix, Stephan B ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Cystatin C; Endothelial dysfunction; Epidemiology; Flow mediated vasodilatation; Renal dysfunction

Indexed keywords

C REACTIVE PROTEIN; CYSTATIN C;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; VASODILATATION;

BIOLOGICAL MARKERS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; RISK FACTORS; VASODILATION;

EID: 77955267219     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.03.023     Document Type: Article

References (25)

1. Cheung A.K., Sarnak M.J., Yan G., et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000, 58:353-362.
2. Brugts J.J., Knetsch A.M., Mattace-Raso F.U., Hogman A., Witteman J.C. Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study. Arch Intern Med 2005, 165:2659-2665.
3. Manjunath G., Tighiouart H., Coresh J., et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003, 63:1121-1129.
4. Newman D.J., Thakkar H., Edwards R.G., et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995, 47:312-318.
5. Mussap M., Dalla Vestra M., Fioretto P., et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002, 61:1453-1461.
6. Larsson A., Malm J., Grubb A., Hansson L.O. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/l. Scand J Clin Lab Invest 2004, 64:25-30.
7. Stevens L.A., Coresh J., Schmid C.H., et al. Estimating GFR using serum cystatin C and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis 2008, 51:395-406.
8. Foster M.C., Keyes M.J., Larson M.G., et al. Relations of measures of endothelial function and kidney disease: the Framingham Heart Study. Am J Kidney Dis 2008, 52:859-867.
9. Halcox J.P., Donald A.E., Ellins E., et al. Endothelial function predicts progression of carotid intima-media thickness. Circulation 2009, 119:1005-1012.
10. Yeboah J., Crouse J.R., Hsu F.C., Burke G.L., Herrington D.M. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007, 115:2390-2397.
11. Doshi S.N., Naka K.K., Payne N., et al. Flow-mediated dilation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci 2001, 101:629-635.
12. Yeboah J., Folsom A., Burke G.L., et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study. The Multi-Ethnic Study of Atherosclerosis. Circulation 2009, 120:502-509.
13. Perticone F., Maio R., Tripepi G., Zoccali C. Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 2004, 110:821-825.
14. John U., Greiner B., Hensel E., et al. Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Sozial- und Präventivmedizin 2001, 46:186-194.
15. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
16. Völzke H., Robinson D.M., Spielhagen T., et al. Are serum thyrotropin levels within the reference range associated with endothelial function?. Eur Heart J 2009, 30:217-224.
17. Wolff B., Lodziewski S., Bollmann T., Opitz C.F., Ewert R. Impaired endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost. Am Heart J 2007, 153. 1088.e1-e7.
18. Jager K.J., Zoccali C., MacLeod A., Dekker F.W. Confounding: what it is and how to deal with it. Kidney Int 2008, 73:256-260.
19. Longenecker J.C., Coresh J., Powe N.R., et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE study. J Am Soc Nephrol 2002, 13:1918-1927.
20. Bongartz L., Cramer M.J., Doevendans P.A., Joles J.A., Braam B. The severe cardiorenal syndrome: Guyton revisted. Eur Heart J 2005, 26:11-17.
21. Luc G., Bard J.M., Lesueur C., et al. Plasma cystatin-C and development of coronary heart disease: The PRIME Study. Atherosclerosis 2006, 185:375-380.
22. Menon V., Shlipak M.G., Wang X., et al. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 2007, 147:19-27.
23. Shlipak M.G., Katz R., Sarnak M.J., et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006, 145:237-246.
24. Henry R.M.A., Kamp O., Kostiense P.J., et al. Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women: an arterial stiffness-related phenomenon-The Hoorn Study. Kidney Int 2005, 68:673-679.
25. Chen R.C., Kumar S., Timmis A., Feder G., Yaqoob M.M., Hemingway H. Comparison of the relation between renal impairment, angiographic coronary artery disease, and long-term mortality in women versus men. Am J Cardiol 2006, 97:630-632.